Yi-Chun Lee

Yi-Chun Lee practices at Good Samaritan University Hospital in West Islip, New York, part of Diocese of Rockville Centre.

Yi-Chun Lee's NPI, 1841274131, was assigned on December 1, 2005. Yi-Chun Lee graduated from Lewis Katz School of Medicine in 1993. Yi-Chun Lee holds New York license 207434-1.

Yi-Chun Lee's primary practice is Good Samaritan University Hospital, at 1000 Montauk Highway, West Islip, NY 11795 in Suffolk County. The practice phone is (631) 376-3000.

Yi-Chun Lee's primary practice is Good Samaritan University Hospital in West Islip, New York, part of Diocese of Rockville Centre. The medical group on file is Cardiac Interventional Group. Dmand AI also links Yi-Chun Lee to 3 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Yi-Chun Lee practices, 4 sites in all. Vendor and product names are available with a free account.

Obstetrics and gynecology is Yi-Chun Lee's primary specialty in the NPI Registry, under taxonomy code 207V00000X. Yi-Chun Lee is board certified in gynecologic oncology by the American Board of Obstetrics and Gynecology. Dmand AI has Yi-Chun Lee's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists hysterectomy, menopause and ovarian cyst among the conditions Yi-Chun Lee treats.

CMS data shows 90 Medicare services from Yi-Chun Lee across 3 procedure codes in 2024, all of them office visits, for 60 Medicare patients. Medicare paid $10,021 for them. Every service was in an office.

CMS counts 60 Medicare patients who saw Yi-Chun Lee in 2024. The largest group is 75 to 84, with 25 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 33% are also on Medicaid. Their average risk score is 1.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Yi-Chun Lee's median patient age at 59, with 96% women.

In 2024, Yi-Chun Lee wrote 26 Medicare Part D claims for 13 patients. 62% of them were for generic drugs. They cover 6 drugs, with $355,849 in total drug cost. In 2020, CMS named 302 claims across 11 drugs.

Dmand AI links 34 papers to Yi-Chun Lee, published from 2009 to 2022. 2015 was the busiest year, with 3. The most frequent topics are Uterine Neoplasms, Carcinosarcoma and Endometrial Neoplasms. Yi-Chun Lee has published most often in Gynecol Oncol. Yi-Chun Lee's most frequent co-authors are Constantine Gorelick, MD, Ovadia Abulafia, MD and Jennifer McEachron, DO.

Dmand AI links Yi-Chun Lee to 2 clinical trials. 1 is still active or recruiting. Conditions studied include Ovarian Neoplasms, Uterine Cervical Neoplasms and Ovarian Diseases. Open Payments lists research payments to Yi-Chun Lee that name 2 trials.

CMS Open Payments shows 162 general payments to Yi-Chun Lee from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 72% of the total. Seagen Inc. paid the most, $11,293. It also lists 10 research payments totaling $1,131 from 2016 to 2019, naming 2 clinical trials.

Dmand AI lists 1 award for Yi-Chun Lee.

Yi-Chun Lee graduated from Lewis Katz School of Medicine in 1993. Yi-Chun Lee is a member of American College of Obstetricians and Gynecologists.

Yi-Chun Lee is in network with 17 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.